A Scalp-EEG Tool for Epilepsy Diagnosis: Getting Patients the Right Answers, Faster
March 11 @ 2:30 pm - 3:30 pm
Every year, over one million people in the U.S. rush to the emergency room after experiencing their first seizure or seizure-like event. For many, the journey that follows is frustrating and uncertain. Epilepsy is notoriously difficult to diagnose – so much so that nearly 30% of patients receive the wrong diagnosis. The most common mistake? Being told they have epilepsy when they do not. These misdiagnosed patients spend months or even years trying ineffective medications, enduring unnecessary side effects, and living with the fear of seizures they don’t actually have only to later discover they have a completely different condition. Why is diagnosing epilepsy so difficult? Unlike other diseases, there has been no reliable biomarker. Our team has identified an EEG-based biomarker for epilepsy, a game-changing discovery that is currently being tested in three major epilepsy centers across the U.S. This new tool, EpiScalp, has the potential to revolutionize epilepsy diagnosis, ensuring patients receive the right answers and the right treatment from their very first visit to a <a href="http://neurologist.
Speaker(s):” target=”_blank” title=”neurologist.
Speaker(s):”>neurologist.
Speaker(s): Sridevi Sarma, PhD – EMBS Distinguished Lecturer